NEW YORK (GenomeWeb) – Becton Dickinson announced today that it has submitted a pre-market approval application with the US Food and Drug Administration for its Onclarity HPV assay for human papillomavirus.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.